Postpartum Hemorrhage, Uterine Atony
Conditions
Keywords
postpartum hemorrhage, uterine atony, cesarean section, cesarean hysterectomy, acute blood loss anemia, uterotonics, obstetric hemorrhage, severe hemorrhage, blood transfusion, obstetric emergencies, obstetrics, massive hemorrhage, hemorrhage, uterine cooling
Brief summary
The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section. The investigators suspect that it may.
Detailed description
Study Design: Patients will be randomly assigned to either the study group or the control group. Patients may receive regional (epidural or spinal/epidural) or general anesthesia.Initially, the investigators plan to enroll 200 subjects, 100 to the study group and 100 to the control group. Following delivery of the fetus, patients in the study group also will have Pitocin® administered to them according to the usual protocol.Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. The skin of the abdomen will be draped to prevent contact with the cold towels. Additional uterotonic medications may be given at the discretion of the attending obstetrician. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen. The surface temperature of the uterus will be measured using an infrared thermometer prior to replacing the uterus into the abdomen. Two surgical suction canisters will be available. Immediately after delivery of the fetus and prior to delivery of the placenta, the amniotic fluid and blood on the surgical field will be aspirated into the first canister. The second suction canister will be used to aspirate blood and fluid until the conclusion of the operation. At the conclusion of the surgery blood loss will be calculated by measuring the content of blood in the second canister minus the amount of irrigation fluid used, and by weighing the surgical sponges. Average blood loss during cesarean sections has previously been reported as 500 to 1000 cc. The duration of cooling the uterus will be recorded. Use and amount of uterotonic medications also will be recorded. During the surgery the patient's vital signs will be monitored in the usual fashion. Particular attention will be paid to a change in her temperature. Warmed blankets and forced air warming blankets will be used to maintain normothermia, if required. At the conclusion of the study the amount of blood loss between the control and study groups, and the amount of uterotonic drugs will be calculated and compared. The number of patients in each group who require additional surgeries, e.g. hysterectomy or D&C, will be monitored. Pre-op and post-op hemograms will be compared if obtained at the discretion of the attending obstetrician. Blood product administration will be recorded. Determination of an ideal temperature of cooling towels is not an objective of the study. We're asking a qualitative question, not a quantitative question at this time. Study Rationale: The uterus is a smooth muscle whose contraction is modulated most directly by intrinsic or extrinsic oxytocin. During pregnancy the spiral arteries within the uterus and beneath the placenta enlarge to provide adequate perfusion to the placenta. After separation of the placenta the uterine smooth muscle cells contract in a pincer-like action to pinch the spiral arteries closed. When uterine contraction is inadequate (approximately 4-6% of normal pregnancies) the spiral arteries continue to bleed. If not addressed the bleeding can be excessive, even leading to maternal death. Approximately 5-8 out of 1,000 cesarean sections require hysterectomy to control bleeding. Release of calcium ions from sarcoplasmic reticulum stores is the immediate initiator of contraction, and calcium's diffusion from the muscle filaments and re-uptake by the sarcoplasmic reticulum results in relaxation of contraction. In some smooth muscles cold enhances contraction; perhaps by slowing the re-uptake of calcium. When the usual pharmacologic agents fail to induce adequate contraction of the uterine smooth muscle, the investigators suspect that application of cold may.
Interventions
Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Sponsors
Study design
Eligibility
Inclusion criteria
* Pregnant adult women of any gravidity, and gestational duration who present for cesarean section at Baylor University Medical Center in Dallas and who have given informed consent to be in the study.
Exclusion criteria
* Women who refuse to be in the study, and women who are unable to consent due to emergent nature of the cesarean section will be excluded. Women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded. * Inability to exteriorize the uterus during c-section.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood Loss | During surgery and in the PACU (approximately 3 total hours) | At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads. |
Secondary
| Measure | Time frame |
|---|---|
| Total Blood Loss Greater Than 1000 cc | Intra-op, Post-Op |
| Requirement of Cesarean Hysterectomy | During surgery and in the PACU (approximately 3 total hours) |
| Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions | Intraoperatively |
| Change in Pre- vs Post-operative Hematocrit | 48 hours post operative period |
| Use of Uterotonic Medications | During surgery and in the PACU (approximately 3 total hours) |
| Use of Extra Oxytocin | Intraoperatively |
| Use of Methergine | Intraoperatively |
| Use of Hemabate | Intraoperatively |
| Use of Cytotec | Intraoperatively |
| Bakri Bulb Placement | Intraoperatively |
| Requirement of Blood Products | During surgery and in the PACU (approximately 3 total hours) |
Other
| Measure | Time frame |
|---|---|
| Patient Temperature | Pre-op, Intra-op, Post-Op |
| Total Time Uterus Wrapped | During hysterotomy repair |
| Uterine Temperature After Wrap Removed | Immediately following hysterotomy repair |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Control Normal cesarean technique. | 100 |
| Uterine Cooling Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen. | 100 |
| Total | 200 |
Baseline characteristics
| Characteristic | Control | Uterine Cooling | Total |
|---|---|---|---|
| Age, Continuous | 30.1 years STANDARD_DEVIATION 4.8 | 31.7 years STANDARD_DEVIATION 5.1 | 30.9 years STANDARD_DEVIATION 5 |
| Fetal Presentation Breech | 14 participants | 14 participants | 28 participants |
| Fetal Presentation Cephalic | 84 participants | 83 participants | 167 participants |
| Fetal Presentation Compound | 0 participants | 1 participants | 1 participants |
| Fetal Presentation Oblique | 1 participants | 0 participants | 1 participants |
| Fetal Presentation Transverse | 1 participants | 2 participants | 3 participants |
| Fetal Weight (g) | 3504 grams STANDARD_DEVIATION 852 | 3471 grams STANDARD_DEVIATION 822 | 3488 grams STANDARD_DEVIATION 835 |
| Gestational Age (wks) | 38.5 weeks STANDARD_DEVIATION 2.2 | 38.0 weeks STANDARD_DEVIATION 4.2 | 38.3 weeks STANDARD_DEVIATION 3.4 |
| Gravidity | 2.5 pregnancies | 2.4 pregnancies | 2.5 pregnancies |
| Height (ft) | 5.4 feet STANDARD_DEVIATION 0.2 | 5.4 feet STANDARD_DEVIATION 0.3 | 5.4 feet STANDARD_DEVIATION 0.3 |
| Multiple Gestations no | 89 participants | 93 participants | 182 participants |
| Multiple Gestations yes | 11 participants | 7 participants | 18 participants |
| Parity | 1.0 births | 1.0 births | 1.0 births |
| Pre-op Epidural no | 91 participants | 83 participants | 174 participants |
| Pre-op Epidural yes | 9 participants | 17 participants | 26 participants |
| Previous Cesareans | 0.8 cesareans | 0.7 cesareans | 0.8 cesareans |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 4 Participants | 5 Participants | 9 Participants |
| Race (NIH/OMB) Black or African American | 14 Participants | 17 Participants | 31 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 82 Participants | 78 Participants | 160 Participants |
| Sex: Female, Male Female | 100 Participants | 100 Participants | 200 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
| Trial of Labor no | 93 participants | 84 participants | 177 participants |
| Trial of Labor yes | 7 participants | 16 participants | 23 participants |
| Weight (lbs) | 200 pounds STANDARD_DEVIATION 49 | 187 pounds STANDARD_DEVIATION 39 | 194 pounds STANDARD_DEVIATION 45 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 100 | 0 / 100 |
| serious Total, serious adverse events | 0 / 100 | 0 / 100 |
Outcome results
Blood Loss
At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.
Time frame: During surgery and in the PACU (approximately 3 total hours)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control | Blood Loss | Intraoperative blood loss | 616 cc | Standard Deviation 411 |
| Control | Blood Loss | PACU blood loss | 141 cc | Standard Deviation 199 |
| Control | Blood Loss | Total blood loss | 756 cc | Standard Deviation 462 |
| Uterine Cooling | Blood Loss | Intraoperative blood loss | 418 cc | Standard Deviation 317 |
| Uterine Cooling | Blood Loss | PACU blood loss | 106 cc | Standard Deviation 170 |
| Uterine Cooling | Blood Loss | Total blood loss | 536 cc | Standard Deviation 429 |
Bakri Bulb Placement
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Bakri Bulb Placement | yes | 3 participants |
| Control | Bakri Bulb Placement | no | 97 participants |
| Uterine Cooling | Bakri Bulb Placement | yes | 0 participants |
| Uterine Cooling | Bakri Bulb Placement | no | 100 participants |
Change in Pre- vs Post-operative Hematocrit
Time frame: 48 hours post operative period
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Change in Pre- vs Post-operative Hematocrit | 4.3 percent | Standard Deviation 3.6 |
| Uterine Cooling | Change in Pre- vs Post-operative Hematocrit | 4.8 percent | Standard Deviation 3.1 |
Requirement of Blood Products
Time frame: During surgery and in the PACU (approximately 3 total hours)
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Requirement of Blood Products | yes | 2 participants |
| Control | Requirement of Blood Products | no | 98 participants |
| Uterine Cooling | Requirement of Blood Products | yes | 3 participants |
| Uterine Cooling | Requirement of Blood Products | no | 97 participants |
Requirement of Cesarean Hysterectomy
Time frame: During surgery and in the PACU (approximately 3 total hours)
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Requirement of Cesarean Hysterectomy | yes | 0 participants |
| Control | Requirement of Cesarean Hysterectomy | no | 100 participants |
| Uterine Cooling | Requirement of Cesarean Hysterectomy | yes | 0 participants |
| Uterine Cooling | Requirement of Cesarean Hysterectomy | no | 100 participants |
Total Blood Loss Greater Than 1000 cc
Time frame: Intra-op, Post-Op
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Total Blood Loss Greater Than 1000 cc | yes | 21 participants |
| Control | Total Blood Loss Greater Than 1000 cc | no | 79 participants |
| Uterine Cooling | Total Blood Loss Greater Than 1000 cc | yes | 9 participants |
| Uterine Cooling | Total Blood Loss Greater Than 1000 cc | no | 91 participants |
Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions | yes | 6 participants |
| Control | Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions | no | 94 participants |
| Uterine Cooling | Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions | yes | 5 participants |
| Uterine Cooling | Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions | no | 95 participants |
Use of Cytotec
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Cytotec | yes | 4 participants |
| Control | Use of Cytotec | no | 96 participants |
| Uterine Cooling | Use of Cytotec | yes | 3 participants |
| Uterine Cooling | Use of Cytotec | no | 97 participants |
Use of Extra Oxytocin
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Extra Oxytocin | yes | 1 participants |
| Control | Use of Extra Oxytocin | no | 99 participants |
| Uterine Cooling | Use of Extra Oxytocin | yes | 1 participants |
| Uterine Cooling | Use of Extra Oxytocin | no | 99 participants |
Use of Hemabate
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Hemabate | yes | 1 participants |
| Control | Use of Hemabate | no | 99 participants |
| Uterine Cooling | Use of Hemabate | yes | 2 participants |
| Uterine Cooling | Use of Hemabate | no | 98 participants |
Use of Methergine
Time frame: Intraoperatively
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Methergine | yes | 2 participants |
| Control | Use of Methergine | no | 98 participants |
| Uterine Cooling | Use of Methergine | yes | 2 participants |
| Uterine Cooling | Use of Methergine | no | 98 participants |
Use of Uterotonic Medications
Time frame: During surgery and in the PACU (approximately 3 total hours)
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Control | Use of Uterotonic Medications | yes | 5 participants |
| Control | Use of Uterotonic Medications | no | 95 participants |
| Uterine Cooling | Use of Uterotonic Medications | yes | 4 participants |
| Uterine Cooling | Use of Uterotonic Medications | no | 96 participants |
Patient Temperature
Time frame: Pre-op, Intra-op, Post-Op
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Control | Patient Temperature | Post-operative | 97.8 degrees Fahrenheit | Standard Deviation 0.4 |
| Control | Patient Temperature | Pre-operative | 98.3 degrees Fahrenheit | Standard Deviation 0.4 |
| Control | Patient Temperature | Intra-operative | 97.7 degrees Fahrenheit | Standard Deviation 1 |
| Uterine Cooling | Patient Temperature | Intra-operative | 97.9 degrees Fahrenheit | Standard Deviation 0.7 |
| Uterine Cooling | Patient Temperature | Pre-operative | 98.4 degrees Fahrenheit | Standard Deviation 0.7 |
| Uterine Cooling | Patient Temperature | Post-operative | 97.9 degrees Fahrenheit | Standard Deviation 1 |
Total Time Uterus Wrapped
Time frame: During hysterotomy repair
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Total Time Uterus Wrapped | 9.3 minutes | Standard Deviation 4.3 |
| Uterine Cooling | Total Time Uterus Wrapped | 9.4 minutes | Standard Deviation 4 |
Uterine Temperature After Wrap Removed
Time frame: Immediately following hysterotomy repair
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control | Uterine Temperature After Wrap Removed | 88.3 degrees Fahrenheit | Standard Deviation 3 |
| Uterine Cooling | Uterine Temperature After Wrap Removed | 75.5 degrees Fahrenheit | Standard Deviation 7.8 |